Jingqian Su

1.7k total citations · 1 hit paper
38 papers, 1.2k citations indexed

About

Jingqian Su is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Jingqian Su has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Jingqian Su's work include Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (9 papers) and Tea Polyphenols and Effects (4 papers). Jingqian Su is often cited by papers focused on Immune Response and Inflammation (9 papers), Sepsis Diagnosis and Treatment (9 papers) and Tea Polyphenols and Effects (4 papers). Jingqian Su collaborates with scholars based in China, United States and France. Jingqian Su's co-authors include Min Huang, Shaoli Cai, Abdullah F. U. H. Saeed, Songying Ouyang, Youqiang Chen, Lu Tang, Kai Guo, Qi Chen, Shun Wu and Qi Chen and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Jingqian Su

38 papers receiving 1.2k citations

Hit Papers

The Pathogenesis of Sepsis and Potential Therapeutic Targets 2019 2026 2021 2023 2019 100 200 300 400 500

Peers

Jingqian Su
Jingqian Su
Citations per year, relative to Jingqian Su Jingqian Su (= 1×) peers Cassiano Felippe Gonçalves-de-Albuquerque

Countries citing papers authored by Jingqian Su

Since Specialization
Citations

This map shows the geographic impact of Jingqian Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingqian Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingqian Su more than expected).

Fields of papers citing papers by Jingqian Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingqian Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingqian Su. The network helps show where Jingqian Su may publish in the future.

Co-authorship network of co-authors of Jingqian Su

This figure shows the co-authorship network connecting the top 25 collaborators of Jingqian Su. A scholar is included among the top collaborators of Jingqian Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingqian Su. Jingqian Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Jingqian, et al.. (2024). Advances in small-molecule insulin secretagogues for diabetes treatment. Biomedicine & Pharmacotherapy. 178. 117179–117179. 7 indexed citations
2.
Su, Jingqian, Siyuan Chen, Xiaoni Zhang, et al.. (2024). Aloin ameliorates cecal ligation and puncture-induced sepsis in mice by attenuating inflammation and modulating gut microbiota. Food Science and Human Wellness. 14(2). 9250034–9250034. 6 indexed citations
3.
Su, Jingqian, Zhihua Feng, Fen Zhou, et al.. (2024). Huperzine a ameliorates sepsis-induced acute lung injury by suppressing inflammation and oxidative stress via α7 nicotinic acetylcholine receptor. International Immunopharmacology. 141. 112907–112907. 3 indexed citations
4.
Su, Jingqian, Shun Wu, Fen Zhou, et al.. (2024). Administration of turmeric kombucha ameliorates lipopolysaccharide-induced sepsis by attenuating inflammation and modulating gut microbiota. Frontiers in Microbiology. 15. 1452190–1452190. 2 indexed citations
5.
Zhang, Yong, et al.. (2024). Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice. Chinese Journal of Natural Medicines. 22(3). 235–248. 3 indexed citations
7.
Su, Jingqian, et al.. (2023). Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents. International Journal of Molecular Sciences. 24(17). 13381–13381. 54 indexed citations
8.
Su, Jingqian, et al.. (2023). Fucoxanthin Ameliorates Sepsis via Modulating Microbiota by Targeting IRF3 Activation. International Journal of Molecular Sciences. 24(18). 13803–13803. 8 indexed citations
9.
Su, Jingqian, et al.. (2023). Research progress on drugs for diabetes based on insulin receptor/insulin receptor substrate. Biochemical Pharmacology. 217. 115830–115830. 17 indexed citations
10.
Su, Jingqian, et al.. (2023). Application of Kombucha Fermentation Broth for Antibacterial, Antioxidant, and Anti-Inflammatory Processes. International Journal of Molecular Sciences. 24(18). 13984–13984. 8 indexed citations
11.
Su, Jingqian, et al.. (2023). Aloe-Emodin Ameliorates Cecal Ligation and Puncture-Induced Sepsis. International Journal of Molecular Sciences. 24(15). 11972–11972. 16 indexed citations
12.
Su, Jingqian, et al.. (2023). Research Progress on the Anti-Aging Potential of the Active Components of Ginseng. Nutrients. 15(15). 3286–3286. 24 indexed citations
13.
Su, Jingqian, et al.. (2023). Research progress on alternative kombucha substrate transformation and the resulting active components. Frontiers in Microbiology. 14. 1254014–1254014. 24 indexed citations
14.
Su, Jingqian, et al.. (2023). Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis. International Journal of Molecular Sciences. 24(16). 12916–12916. 6 indexed citations
15.
Su, Jingqian, et al.. (2023). Research Progress of Macromolecules in the Prevention and Treatment of Sepsis. International Journal of Molecular Sciences. 24(16). 13017–13017. 6 indexed citations
16.
Su, Jingqian, et al.. (2023). Research Progress on Natural Small-Molecule Compounds for the Prevention and Treatment of Sepsis. International Journal of Molecular Sciences. 24(16). 12732–12732. 14 indexed citations
18.
Saeed, Abdullah F. U. H., et al.. (2020). Regulation of cGAS‐Mediated Immune Responses and Immunotherapy. Advanced Science. 7(6). 37 indexed citations
19.
Huang, Min, Shaoli Cai, & Jingqian Su. (2019). The Pathogenesis of Sepsis and Potential Therapeutic Targets. International Journal of Molecular Sciences. 20(21). 5376–5376. 512 indexed citations breakdown →
20.
Su, Jingqian, Kai Guo, Min Huang, et al.. (2019). Fucoxanthin, a Marine Xanthophyll Isolated From Conticribra weissflogii ND-8: Preventive Anti-Inflammatory Effect in a Mouse Model of Sepsis. Frontiers in Pharmacology. 10. 906–906. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026